<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200710048073N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-02-27</date_registration>
      <primary_sponsor>Bagheiat-allah University of Medical Sciences</primary_sponsor>
      <public_title>The effect of Guided Imagery on Nausea and Vomiting and Quality of Life in Cancer Chemotherapy</public_title>
      <acronym></acronym>
      <scientific_title>Exploring the effects of Guided Imagery on Gastrointestinal complications and Quality of Life in Cancer patients undergoing Chemotherapy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-02-28</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/50696</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Considering that the research will be a clinical trial, it consists of two conditions; namely the intervention and random allocation. As a result, the sampling method is firstly based on the criteria of entering the target sampling method and then random allocation with quadruple blocks will be performed in two groups of intervention and control.
The random characteristic method with quadratic blocks includes assignments of the intervention group A and to the observation group B. Six conditions of AABB، BBAA، ABAB، BABA، ABBA، BAAB, 
will be written separately and then will be thrown inside the container. One piece of paper will be randomly removed from the container, followed by writing down the condition. Then, the paper will be taken back into the container. Driven by the sample size, which is 70 patients, this operation will be repeated 15 times. Each time, the condition will be written in order. Each letter is allocated to a number from one to seventy. Each letter is placed in a matte envelope and numbers 1 to 70 are written on the envelope. Each time the disease is selected, one of these envelopes will be opened following the order written on the envelope and will be specified in the group in which the patient should be placed.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Chemotherapy-induced Nausea and Vomiting in Cancer. Condition 2: Quality of Life in Cancer patients undergoing Chemotherapy.</hc_freetext>
      <i_freetext>Intervention 1: The intervention group will be given a Guided Imagery instruction by the researcher during one hour, then the audio file prepared by the researcher will be provided to the intervention group via WhatsApp to listen during Chemotherapy with handsfree. Approximate time to hear the audio file is about 20 minutes. Then people will be asked to listen to an audio file once a day for two months after this Chemotherapy. Intervention 2: The control group will be prevented from hearing environmental noise, by placing handsfree in their ears. On the other hand, they will not receive the audio file of the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Khamseh Feryal</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Baqiyatallah University of Medical Sciences - Sheikh Baha'i St. - Mulla Sadra St. - Vanak</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1435915371</zip>
        <telephone>+98 21 8755 5491</telephone>
        <email>khamseh_110@yahoo.com</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Batool Nehrir</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Baqiyatallah University of Medical Sciences - Sheikh Baha'i St. - Mulla Sadra St. - Vanak</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1435915371</zip>
        <telephone>+98 21 8755 5491</telephone>
        <email>rnehrir1739@yahoo.com</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age above 18 years and under 65 years
Minimum Education Level
Willingness to participate in research
Nausea and Vomiting experience during the Chemotherapy
At least one session of Chemotherapy is performed and at least one course of Chemotherapy has left after enrollment</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Use of Nausea and Vomiting Medications other than routine and use of Complementary Medications such as Ginger
Gastrointestinal Cancer
Performing Radiotherapy simultaneously with Chemotherapy
Hearing disorders
History of Gastrointestinal Surgery
Gastrointestinal Cancer
History of mental disorder
The participant is a member of the Healthcare team
Have taken psychological skills training courses such as relaxation</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C00-D49</hc_code>
      <hc_code>C00-D49</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Neoplasms of unspecified behavior</hc_keyword>
      <hc_keyword>Neoplasms of unspecified behavior</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention group will be given a Guided Imagery instruction by the researcher during one hour, then the audio file prepared by the researcher will be provided to the intervention group via WhatsApp to listen during Chemotherapy with handsfree. Approximate time to hear the audio file is about 20 minutes. Then people will be asked to listen to an audio file once a day for two months after this Chemotherapy.</i_keyword>
      <i_keyword>The control group will be prevented from hearing environmental noise, by placing handsfree in their ears. On the other hand, they will not receive the audio file of the intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Nausea and Vomiting. Timepoint: Pre-intervention، post-intervention and two months after the intervention. Method of measurement: Nausea and Vomiting Questionnaire (The Multinational Association of Supportive Care in Cancer.</prim_outcome>
      <prim_outcome>Quality of Life. Timepoint: Pre-intervention and two months after the intervention. Method of measurement: Quality of Life Questionnaire - ( European Organization for Research and Treatment of Cancer).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Nausea and Vomiting. Timepoint: Pre-intervention and after Chemotherapy and two months after the intervention. Method of measurement: Questionnaire Antiemesis Tool- The Multinational Association of Supportive Care in Cancer -.</sec_outcome>
      <sec_outcome>Quality of Life. Timepoint: Pre-intervention and two months after the intervention. Method of measurement: Quality of Life Questionnaire - ( European Organization for Research and Treatment of Cancer).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Bagheiat-allah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-11-22</approval_date>
        <contact_name>Ethics Committee of Baqiyatallah University</contact_name>
        <contact_address>Baqiyatallah University of Medical Sciences, Sheikh Baha'i St., Mulla Sadra St., Vanak, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
